Study Summary
This trial is testing a new stroke treatment to see if it is safe and effective. Patients will be given the new treatment or a placebo, and researchers will track how well they recover.
- Stroke
- Ischemic Stroke
- Acute Ischemic Stroke
Treatment Effectiveness
Study Objectives
5 Primary · 4 Secondary · Reporting Duration: multiple times from baseline through Month 12
Trial Safety
Trial Design
2 Treatment Groups
NCS-01
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
16 Total Participants · 2 Treatment Groups
Primary Treatment: NCS-01 · Has Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many volunteers have enrolled in the trial thus far?
"Affirmative. The details available on clinicaltrials.gov verify that this medical study is currently taking enrolment applications, having originally been posted in February 2020 and updated most recently in April 2022. 16 participants are needed to be recruited from a single site." - Anonymous Online Contributor
Does this clinical research include individuals aged 50 and above?
"In accordance with the rules stipulated in this trial's inclusion criteria, it is obligatory that all participants are at least 18 years of age and no older than 80." - Anonymous Online Contributor
To what extent does this investigation seek to accomplish?
"According to the clinical trial sponsor, NC Medical Research Inc., one of the primary objectives is assessing participants' adverse reactions over a 1-hour, 3-hour and 6-hour post infusion period. Additionally, they will be measuring an array of secondary outcomes such as changes in MRI data, Modified Rankin Scale scores and cytokine panel results (IL-1; IL-6; etc)." - Anonymous Online Contributor
What criteria must a participant fulfill to join this research investigation?
"Candidates must meet the criteria of having a wake-up stroke and being between 18 - 80 years old to be qualified for this trial. Approximately 16 individuals will have the opportunity to join." - Anonymous Online Contributor
Is there an ongoing enrollment period for this research trial?
"Affirmative. According to clinicaltrials.gov, this research experiment is actively in search of participants and was initially posted on February 27th 2020 with the most recent update made April 22nd 2022. 16 individuals are needed across 1 facility for participation." - Anonymous Online Contributor